The Effect of Metamin 3D on the Lipid and Glucose in Subjects With Metabolic Syndrome
NCT ID: NCT01120873
Last Updated: 2010-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
110 participants
INTERVENTIONAL
2007-03-31
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus
NCT01018017
A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes
NCT02653599
Safety, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Patients With Type 2 Diabetes Mellitus and Healthy Adults
NCT01042106
Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
NCT01240759
Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
NCT00499707
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Metamin 3D
A randomized, double-blinded and placebo-controlled study
Metamin 3D
Metamin 3D is composed by red yeast rice, bitter gourd, chlorella, soy peptide and licorice extract is a commercial product designed by Uni-President enterprises corp in Taiwan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Metamin 3D
Metamin 3D is composed by red yeast rice, bitter gourd, chlorella, soy peptide and licorice extract is a commercial product designed by Uni-President enterprises corp in Taiwan
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fasting plasma glucose \>= 100 mg/dl
* Triglyceride \>= 150 mg/dl
* one of the criteria following
1. HDL \<40 mg/dl in man or \<50 mg/dl in woman
2. Blood pressure \>= 135/85 mmHg or anti-hypertension drug treatment
3. Waist \>90cm in man or 80cm in woman
* Signed the inform consent
Exclusion Criteria
* Treated by more than two types oral hypoglycemic agents in past 3 months
* Treated continuously by anti-lipid agents for 3 months in past 6 months
* Treated by thiazolidinedione or digitalis at present
* Serum creatine \> 2.5mg/dl
* Liver function (GOT or GPT) more than 3-fold upper limit
* Severe systemic disease by investigator's judgement
* Pregnant or nursing women
* Enrolled in other clinical study in recent 1 month
30 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taichung Veterans General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
I Te Lee, MD
Role: PRINCIPAL_INVESTIGATOR
Taichung Veterans General Hospital, Taichung
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital
Taichang, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S06203
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.